In agreement with this, unsupervised hierarchical clustering segregates almost perfectly human CLL samples according to their disease state (i.e., untreated or resistant to ibrutinib) regardless of their BTK mutational status (Fig. 7C). This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.